Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women

被引:12
|
作者
Anderson, Kristin [1 ]
Thompson, Patricia A. [2 ]
Wertheim, Betsy C. [2 ]
Martin, Lorena [3 ]
Komenaka, Ian K. [4 ]
Bondy, Melissa [5 ]
Daneri-Navarro, Adrian [6 ]
Mercedes Meza-Montenegro, Maria [7 ]
Gutierrez-Millan, Luis Enrique [8 ]
Brewster, Abenaa [9 ]
Madlensky, Lisa [1 ,3 ]
Tobias, Malaika [1 ]
Natarajan, Loki [1 ,3 ]
Martinez, Maria Elena [1 ,3 ]
机构
[1] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[2] Univ Arizona, Tucson, AZ USA
[3] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA
[4] Maricopa Cty Gen Hosp, Phoenix, AZ USA
[5] Baylor Coll Med, Houston, TX 77030 USA
[6] Univ Guadalajara, Guadalajara 44430, Jalisco, Mexico
[7] Inst Tecnol Sonora, Obregon, Mexico
[8] Univ Sonora, Hermosillo 83000, Sonora, Mexico
[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源
SPRINGERPLUS | 2014年 / 3卷
关键词
Triple negative breast cancer; Hispanic; Family history; Risk factor heterogeneity; PROGESTERONE-RECEPTOR STATUS; JOINT ESTROGEN-RECEPTOR; RISK-FACTORS; REPRODUCTIVE FACTORS; MOLECULAR SUBTYPES; HORMONE-RECEPTOR; TUMOR SUBTYPES; ASSOCIATION; COLLECTION; ACCURACY;
D O I
10.1186/2193-1801-3-727
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Familial breast and ovarian cancer prevalence was assessed among 1150 women of Mexican descent enrolled in a case-only, binational breast cancer study. Logistic regression was conducted to compare odds of triple negative breast cancer (TNBC) to non-TNBC according to family history of breast and breast or ovarian cancer among 914 of these women. Prevalence of breast cancer family history in a first- and first- or second-degree relative was 13.1% and 24.1%, respectively; that for breast or ovarian cancer in a first-degree relative was 14.9%. After adjustment for age and country of residence, women with a first-degree relative with breast cancer were more likely to be diagnosed with TNBC than non-TNBC (OR=1.98; 95% CI, 1.26-3.11). The odds of TNBC compared to non-TNBC were 1.93 (95% CI, 1.26-2.97) for women with a first- degree relative with breast or ovarian cancer. There were non-significant stronger associations between family history and TNBC among women diagnosed at age <50 compared to >= 50 years for breast cancer in a first-degree relative (P-interaction = 0.14) and a first- or second-degree relative (P-interaction = 0.07). Findings suggest that familial breast cancers are associated with triple negative subtype, possibly related to BRCA mutations in Hispanic/Latina women, which are strongly associated with TNBC. Family history is an important tool to identify Hispanic/Latina women who may be at increased risk of TNBC, and could benefit from prevention and early detection strategies.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Cancer screening and breast cancer family history in Spanish-speaking Hispanic/Latina women in California
    Tamayo, Lizeth I.
    Perez, Fabian
    Perez, Angelia
    Hernandez, Miriam
    Martinez, Alejandra
    Huang, Xiaosong
    Zavala, Valentina
    Ziv, Elad
    Neuhausen, Susan L.
    Carvajal-Carmona, Luis
    Duron, Ysabel
    Fejerman, Laura
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (01) : 273 - 274
  • [2] Cancer screening and breast cancer family history in Spanish-speaking Hispanic/Latina women in California
    Tamayo, Lizeth I.
    Perez, Fabian
    Perez, Angelica
    Hernandez, Miriam
    Martinez, Alejandra
    Huang, Xiaosong
    Zavala, Valentina A.
    Ziv, Elad
    Neuhausen, Susan L.
    Carvajal-Carmona, Luis G.
    Duron, Ysabel
    Fejerman, Laura
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Relationship between ancestry fractions and gene expression in triple-negative breast cancer in Hispanic/Latina women
    Carrasquilla, Laura
    Garai, Jone
    Serrano-Gomez, Silvia J.
    Sanabria-Salas, Maria C.
    Baddoo, Melody C.
    Fejerman, Laura
    Zabaleta, Jovanny
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [4] Risk Factors for Triple-Negative Breast Cancer among Latina Women
    Rey-Vargas, Laura
    Carolina Sanabria-Salas, Maria
    Fejerman, Laura
    Serrano-Gomez, Silvia J.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (11) : 1771 - 1783
  • [5] Ovarian cancer screening in women with a family history of breast or ovarian cancer
    Lacey, James V., Jr.
    Greene, Mark H.
    Buys, Saundra S.
    Reding, Douglas
    Riley, Thomas L.
    Berg, Christine D.
    Fagerstrom, Richard M.
    Hartge, Patricia
    [J]. OBSTETRICS AND GYNECOLOGY, 2006, 108 (05): : 1176 - 1184
  • [6] Association between tumor mutation profile and clinical outcomes among Hispanic Latina women with triple-negative breast cancer
    Philipovskiy, Alexander
    Dwivedi, Alok
    Gamez, Roberto
    McCallum, Richard
    Nahleh, Zeina
    Aguilera, Renato
    Gaur, Sumit
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [7] Association between tumor mutation profile and clinical outcomes among Hispanic Latina women with triple-negative breast cancer
    Philipovskiy, Alexander
    Dwivedi, Alok K.
    Gamez, Roberto
    McCallum, Richard
    Mukherjee, Debabrata
    Nahleh, Zeina
    Aguilera, Renato J.
    Gaur, Sumit
    [J]. PLOS ONE, 2020, 15 (09):
  • [8] Differences in estrogen receptor subtype according to family history of breast cancer among Hispanic, but not non-Hispanic White women
    Hines, Lisa M.
    Risendal, Betsy
    Slattery, Martha L.
    Baumgartner, Kathy B.
    Giuliano, Anna R.
    Byers, Tim
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (10) : 2700 - 2706
  • [9] BRCA mutations among triple negative breast cancer without family history of breast and ovarian cancer: The Modena family cancer clinic experience
    Molinaro, E.
    Venturelli, M.
    Toss, A.
    Piombino, C.
    Barbieri, E.
    Marcheselli, L.
    Marchi, I.
    Tagliafico, E.
    Cascinu, S.
    Cortesi, L.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [10] The hispanic landscape of triple negative breast cancer
    Zevallos, Alejandra
    Bravo, Leny
    Bretel, Denisse
    Paez, Kevin
    Infante, Ulises
    Cardenas, Nadezhda
    Alvarado, Hober
    Posada, Ana M.
    Pinto, Joseph A.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 155